140 related articles for article (PubMed ID: 20213656)
1. Effect of vascular endothelial growth factor on nasal vascular permeability.
Matsune S; Ohori J; Yoshifuku K; Kurono Y
Laryngoscope; 2010 Apr; 120(4):844-8. PubMed ID: 20213656
[TBL] [Abstract][Full Text] [Related]
2. Involvement of thromboxane A2 and histamine in experimental allergic rhinitis of guinea pigs.
Yamasaki M; Matsumoto T; Fukuda S; Nakayama T; Nagaya H; Ashida Y
J Pharmacol Exp Ther; 1997 Mar; 280(3):1471-9. PubMed ID: 9067337
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor produced in nasal glands of perennial allergic rhinitis.
Matsune S; Ohori J; Sun D; Yoshifuku K; Fukuiwa T; Kurono Y
Am J Rhinol; 2008; 22(4):365-70. PubMed ID: 18702899
[TBL] [Abstract][Full Text] [Related]
4. Expression, localization, and significance of vascular permeability/vascular endothelial growth factor in nasal polyps.
Gosepath J; Brieger J; Lehr HA; Mann WJ
Am J Rhinol; 2005; 19(1):7-13. PubMed ID: 15794068
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of tissue vascular endothelial growth factor and foetal liver kinase-1 receptor in seasonal allergic rhinitis and relevance to asthma component.
Yuksel H; Kose C; Yilmaz O; Ozbilgin K; Degirmenci PB; Pinar E; Kirmaz C
Clin Exp Allergy; 2007 Aug; 37(8):1183-8. PubMed ID: 17651148
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor in allergen-induced nasal inflammation.
Choi GS; Park HJ; Hur GY; Choi SJ; Shin SY; Ye YM; Park HS
Clin Exp Allergy; 2009 May; 39(5):655-61. PubMed ID: 19236408
[TBL] [Abstract][Full Text] [Related]
7. [The effect of KW-4679, an antiallergic drug, on experimental allergic rhinitis].
Kaise T; Manabe H; Ohmori K
Arerugi; 1995 Oct; 44(10):1229-33. PubMed ID: 8579485
[TBL] [Abstract][Full Text] [Related]
8. [Effect of amlexanox on experimental allergic rhinitis in actively sensitized guinea pigs].
Ukai K; Atsushi ; Yuda ; Nonoyama T; Sakakura Y; Ahida Y
Arerugi; 1990 Jan; 39(1):54-8. PubMed ID: 2350243
[TBL] [Abstract][Full Text] [Related]
9. Nasal allergic response mediated by histamine H3 receptors in murine allergic rhinitis.
Nakaya M; Fukushima Y; Takeuchi N; Kaga K
Laryngoscope; 2005 Oct; 115(10):1778-84. PubMed ID: 16222194
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of nasal barrier dysfunction at acute- and late-phase reactions in a guinea pig model of allergic rhinitis.
Elovsson S; Smailagic A; Erjefalt I; Zackrisson C; Eriksson C; Wang X
Vascul Pharmacol; 2005 Oct; 43(4):267-76. PubMed ID: 16257271
[TBL] [Abstract][Full Text] [Related]
11. Effect of olopatadine hydrochloride, an anti-histamine drug, on rhinitis induced by intranasal instillation of toluene-2,4-diisocyanate in rats.
Tamura T; Komai M
Int Immunopharmacol; 2008 Jun; 8(6):916-21. PubMed ID: 18442798
[TBL] [Abstract][Full Text] [Related]
12. Effect of histamine on the permeability of the nasal mucosa in vivo.
Yang TQ; Takeuchi K; Hayashi S; Majima Y
Acta Otolaryngol; 2003 Apr; 123(3):401-5. PubMed ID: 12737298
[TBL] [Abstract][Full Text] [Related]
13. Anti-allergic and anti-inflammatory properties of a potent histamine H1 receptor antagonist, desloratadine citrate disodium injection, and its anti-inflammatory mechanism on EA.hy926 endothelial cells.
Jie Q; Kodithuwakku ND; Yuan X; He G; Chen M; Xu S; Wu Y
Eur J Pharmacol; 2015 May; 754():1-10. PubMed ID: 25704613
[TBL] [Abstract][Full Text] [Related]
14. [Oral second generation antihistamines in allergic rhinitis].
Riechelmann H
Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
[TBL] [Abstract][Full Text] [Related]
15. Allergic rhinitis and vascular endothelial growth factor.
Matsune S
J Nippon Med Sch; 2012; 79(3):170-5. PubMed ID: 22791116
[TBL] [Abstract][Full Text] [Related]
16. The roles of histamine, leukotriene C4 and bradykinin on nasal vascular permeability in experimental nasal allergy of guinea pigs.
Shirasaki H; Asakura K; Kojima T; Sohma S; Kataura A
Rhinology; 1992 Mar; 30(1):41-8. PubMed ID: 1374569
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of angiogenic markers in patients with seasonal allergic rhinitis.
Kirmaz C; Ozbilgin K; Yuksel H; Bayrak P; Unlu H; Giray G; Kiliccioglu B
Eur Cytokine Netw; 2004; 15(4):317-22. PubMed ID: 15627640
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of a T cell epitope inhibits symptoms and reactions of allergic rhinitis in Japanese cedar pollen allergen-sensitized mice.
Murasugi T; Nakagami Y; Yoshitomi T; Hirahara K; Yamashita M; Taniguchi Y; Sakaguchi M; Ito K
Eur J Pharmacol; 2005 Mar; 510(1-2):143-8. PubMed ID: 15740735
[TBL] [Abstract][Full Text] [Related]
19. Effect of systemically administered H1- and H2-receptor antagonists on nasal blood flow as measured with laser Doppler flowmetry in a provoked allergic reaction.
Juliusson S; Bende M
Rhinology; 1996 Mar; 34(1):24-7. PubMed ID: 8739864
[TBL] [Abstract][Full Text] [Related]
20. Thresholds in nasal histamine challenge in patients with allergic rhinitis, patients with hyperreflectory rhinopathy, and healthy volunteers.
Wuestenberg EG; Hauswald B; Huettenbrink KB
Am J Rhinol; 2004; 18(6):371-5. PubMed ID: 15706984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
